2022 Revenues ($USD) : $1,010,635,000
2022 R&D spend : $43,565,000
2022 Number of Employees : 3,800
Fiscal Year End : 12/31/2021
Company CEO : Curt Hartman, president and CEO

Conmed has been active on the M&A front in 2022. The Largo, Florida–based company bought upper extremities device maker In2Bones Global for $145 million in June, then announced an agreement to acquire bioinductive scaffold startup Biorez for up to $250 million in August. Founded in 1970 and initially based in Utica, New York, before moving headquarters to Florida in 2021, Conmed employs approximately 3,800 people. –SW